Cricket

Bangladesh Cricket Board to launch vaccination drive for players

  • Agence France-Presse
  • January 28th, 2021
  • 12:27:45 IST

The Bangladesh Cricket Board said Thursday it will vaccinate hundreds of players against the coronavirus by the end of February in a bid to restart domestic tournaments.

Apart from two small events last year and the current tour by the West Indies - which were held in strict bio-bubbles - all play has been suspended since March.

The Bangladesh Cricket Board has ruled out resuming cricket at all levels until all players are vaccinated.

The jabs will be given to the top 500 players as part of the new campaign.

The board did not spell out how it would get the vaccines. But BCB president Nazmul Hassan is also chief executive of Beximco Pharmaceuticals, which has signed a deal to procure 30 million vaccine doses from India for the Bangladesh government.

Beximco said it also plans to buy vaccines to sell on the open market.

Bangladesh this week received two million vaccine doses from India and launched an anti-coronavirus drive Wednesday with 27 people, including nurses and doctors, receiving the first available vaccines.

Authorities have said a wider inoculation programme will start on 7 February.

Bangladesh has recorded 533,000 coronavirus cases and more than 8,000 deaths.

Updated Date: January 28, 2021 12:27:45 IST

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Johnson & Johnson's upcoming COVID-19 vaccine trials to include infants
science

Johnson & Johnson's upcoming COVID-19 vaccine trials to include infants

Pfizer-BioNTech and Moderna plan to gradually test their vaccines in younger and younger age groups.

Reliance, Infosys, Accenture to cover COVID-19 vaccination costs for employees
India

Reliance, Infosys, Accenture to cover COVID-19 vaccination costs for employees

Accenture and Infosys are among the first technology services providers to cover the cost of vaccination for its employees their dependents who are part of the company's medical benefits scheme

AstraZeneca vaccine is 80.4%, Pfizer vaccine is 71.4% effective in elderly people: Study
science

AstraZeneca vaccine is 80.4%, Pfizer vaccine is 71.4% effective in elderly people: Study

Although the vaccine developers and WHO insist that the vaccine is effective among people aged over 65, several countries advise against administering it.